Maravai Lifesciences Holdings, Inc.(MRVI)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
MRVI is scheduled to report on Nov 4, 2026, after the market closes. Analysts expect EPS of -$0.06.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±18.9%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 6 misses.
In plain words: it beat expectations 5 times, but the stock still fell 1 of those 5 times.
- Aug '26Beat▼ -0.3%
- May '26Beat▲ +23.1%
- Feb '26Beat▲ +9.2%
- Aug '25Missed▲ +30.6%
- May '25Missed▼ -2.8%
- Mar '25Missed▼ -5.8%
- Nov '24Missed▼ -35.3%
- May '24Beat▲ +11.2%
- Feb '24Beat▲ +63.6%
- Nov '23Missed▼ -31.7%
- May '23Missed▼ -13.0%
Clear beats and misses with a known reaction only. What counts as a beat
Why did MRVI fall after beating earnings?
2 of MRVI's last 11 reactions went against the EPS result. What stands out in each:
MRVI beat EPS estimates in 5 quarters, and the stock still closed lower the next day 1 time.
- Aug 6, 2026EPS beat +50.0%stock -0.3% next day
- It opened 10.4% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 6)
- Aug 11, 2025EPS missed -14.3%stock +30.6% next day
- It had already fallen 22.8% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 13.1% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was MRVI's earnings move already priced in?
MRVI's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does MRVI hold its opening gap after earnings?
MRVI's opening move after each report and where it closed that day.
In 10 reports MRVI opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 10 times (20%). Gaps up faded 0 of 5; gaps down recovered 2 of 5.
- Aug 6, 2026FadedOpened -10.4%, closed -0.3%
- May 7, 2026HeldOpened +11.4%, closed +23.1%
- Feb 25, 2026HeldOpened +9.8%, closed +9.2%
- Nov 6, 2025FadedOpened -11.9%, closed -0.7%
- Aug 11, 2025HeldOpened +13.1%, closed +30.6%
- Nov 7, 2024HeldOpened -39.4%, closed -35.3%
- May 8, 2024HeldOpened +3.2%, closed +11.2%
- Feb 22, 2024HeldOpened +36.0%, closed +63.6%
What the history says
- MRVI has beaten EPS estimates in 3 straight quarters.
MRVI earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | After close | -$0.04 | -$0.02 | +50.0% | -0.32% | -7.04% |
| May 7, 2026 | After close | -$0.05 | $0.01 | +120.0% | +23.10% | +18.27% |
| Feb 25, 2026 | After close | -$0.07 | -$0.04 | +42.9% | +9.20% | +10.74% |
| Nov 6, 2025 | After close | -$0.08 | -$0.08 | 0.0% | -0.69% | +12.46% |
| Aug 11, 2025 | After close | -$0.07 | -$0.08 | -14.3% | +30.58% | +26.21% |
| May 12, 2025 | After close | -$0.07 | -$0.08 | -14.3% | -2.83% | -7.55% |
| Mar 18, 2025 | After close | -$0.04 | -$0.06 | -50.0% | -5.81% | -12.21% |
| Nov 7, 2024 | After close | -$0.01 | -$0.02 | -100.0% | -35.27% | -27.30% |
| May 8, 2024 | After close | -$0.03 | -$0.02 | +33.3% | +11.16% | +18.71% |
| Feb 22, 2024 | After close | -$0.01 | $0.01 | +200.0% | +63.60% | +61.64% |
| Nov 7, 2023 | After close | $0.01 | -$0.01 | -200.0% | -31.69% | -25.44% |
| May 8, 2023 | After close | $0.04 | $0.03 | -25.0% | -13.02% | -1.51% |
Consensus for the next report: EPS -$0.06, revenue $44.44M.
MRVI Earnings FAQ
Answers computed from Maravai Lifesciences Holdings, Inc.'s reported history
MRVI is scheduled to report on Nov 4, 2026, after the market closes. Analysts expect EPS of -$0.06.
Over the last 12 quarters with a usable EPS surprise, MRVI beat the consensus estimate 5 times (42%), missed 6 and landed in line 1. It has beaten estimates in each of the last 3 counted quarters.
Across its last 12 quarters with a measured reaction, MRVI moved an average of ±18.9% in the first session after reporting. It closed higher 42% of the time; the largest gain was 63.6% and the largest drop -35.3%.
MRVI fell in the first session after 1 of its last 5 EPS beats (20%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 12 quarters with price data, MRVI moved an average of -5.9% in the 20 trading sessions before reporting and was higher in 42% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging +7.8%. After a drop of 3% or more (6 quarters), it rose the next day 50% of the time, averaging +10.9%. This describes past reports; it is not a forecast.
In 10 reports MRVI opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 10 times (20%), and fully reversed 0 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · MRVI: 12 reported quarters, latest Aug 6, 2026. Information only, not investment advice.
Looking for more on MRVI?
Price charts, forecast, fundamentals and risk pages for MRVI are not on Tickzen yet. You can run a full stock analysis now.
Run the MRVI Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun